Condition

Neuromyelitis Optica Spectrum Disorders clinical trials and research

• 9Clinical trials
• 4Countries

Newest Neuromyelitis Optica Spectrum Disorders clinical trials

All recruiting trials (9)

• Using ultra-high field and metabolic MRI to understand resilience and degeneration in the aging and diseased brain

  This project will try advanced 3T and 7T MRI scans, including sodium and phosphorus imaging, to see if metabolic and connectivity changes explain resilience and degeneration in adults with MS, NMOSD, MOGAD, Alzheimer’s, Parkinson’s, or healthy aging.

  Recruiting Assistance Publique Hopitaux De Marseille · Marseille · NCT07202494

• Universal CD19/BCMA CAR T-cell therapy for relapsed or refractory neurological autoimmune diseases

  This will test whether a single infusion of universal CD19/BCMA CAR T-cells given after chemotherapy helps adults with relapsed or refractory neurological autoimmune diseases who have CD19- or BCMA-positive B cells.

  Recruiting Early Phase 1 Tianjin Huanhu Hospital · Tianjin · NCT06939166

• Assessing genetic variations in patients with neuromyelitis optica and multiple sclerosis

  This study is trying to see if certain genetic differences in the FCGR3A gene are more common in Italian adults with neuromyelitis optica, MOGAD, or multiple sclerosis.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma, Roma · NCT06865274

• Treatment for acute episodes of neuromyelitis optica spectrum disorder using protein A immunoadsorption

  This study is testing whether a new treatment using protein A immunoadsorption can help people with neuromyelitis optica spectrum disorder feel better during acute flare-ups compared to just using high-dose steroids.

  Recruiting Third Affiliated Hospital, Sun Yat-Sen University · Guangzhou, Guangdong · NCT06763848

• Evaluating JYP0061 for treating acute Neuromyelitis Optica Spectrum Disorders

  This study is testing a new treatment called JYP0061 to see if it can help people with acute Neuromyelitis Optica Spectrum Disorders feel better and stay safe while using it.

  Recruiting Phase 2 Guangzhou JOYO Pharma Co., Ltd · Changsha, Hunan · NCT06697535

• Evaluating NouvSoma001 for treating Neuromyelitis Optica Spectrum Disorders

  This study is testing a new treatment called NouvSoma001 to see if it can help people with Neuromyelitis Optica Spectrum Disorders feel better and stay safe while using it.

  Recruiting Phase 1 Tongji Hospital · Wuhan, Hubei · NCT06620809

• Observational study on CNS inflammatory demyelinating diseases in the Chinese population

  This study is looking to understand how certain brain diseases, like Multiple Sclerosis, affect people in China and what factors might influence their progression and treatment.

  Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT06541626

• Treatment of Neuromyelitis Optica Spectrum Disorders with B001 Injection

  This study is testing if a new injection called B001 can help people with neuromyelitis optica spectrum disorders who have had multiple flare-ups feel better and have fewer recurrences.

  Recruiting at 51 sites Phase 2/3 Shanghai Jiaolian Drug Research and Development Co., Ltd · Beijing and 50 other locations · NCT06413654

• Investigating risk factors for disability progression in Multiple Sclerosis

  This study is trying to find out what factors might make disability get worse in people with Multiple Sclerosis by looking at their medical history and MRI scans.

  Recruiting Cedars-Sinai Medical Center · Los Angeles, California · NCT05204459

Related topics

Quick answers

How many Neuromyelitis Optica Spectrum Disorders clinical trials are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in China (6 trials), Italy (1 trial), United States (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 2/3: 1, Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →